Thursday, February 9, 2012
Introducing Mood 24/7, a new tool that helps you track your mood from day to day using your mobile phone. Try it today!

Symbyax approved for treatment-resistant depression

(Reuters) UPDATED 2009-03-23
The U.S. Food and Drug Administration (FDA) has approved Symbyax for use in patients with treatment-resistant depression, drugmaker Eli Lilly is reporting. Symbyax combines two medications, the antipsychotic Zyprexa and the antidepressant Prozac. According to its maker, Symbyax is the first drug approved by the FDA for the acute treatment of treatment-resistant depression, which involves two failed attempts with other antidepressants.  Read full story >
See all Bipolar News
Related: Symbyax

People who read this also read...